RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제
      • 좁혀본 항목 보기순서

        • 원문유무
        • 원문제공처
        • 등재정보
        • 학술지명
        • 주제분류
        • 발행연도
        • 저자
          펼치기

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        중심망막정맥폐쇄 환자에서 덱사메타손 유리체강내 삽입물 주입 시 발생한 분절화 1예

        윤상문,박성진,이호영,임성협,윤일한,Sang Moon Youn,MD,Sung Jin Park,MD,Ho Young Lee,MD,Sung Hyup Lim,MD,Il Han Yun,MD,PhD 대한안과학회 2013 대한안과학회지 Vol.54 No.6

        Purpose: We report a case of dexamethasone intravitreal implant (Ozurdex?; Allergan, Inc.) fragmentation during the injection procedure in macular edema due to central retinal vein occlusion. Case summary: A 57-year-old man visited our hospital for visual disturbance in his right eye. The patient’s best-corrected visual acuity was 0.02 in the right eye and 1.2 in the left eye. After fundus examination, the patient was diagnosed with central retinal vein occlusion with macular edema, thus bevacizumab was injected in the right eye. However, the macular edema did not improve, and a dexamethasone intravitreal implant was injected in the right eye. Immediately after the dexamethasone intravitreal implant injection, on fundus exam, the drug was observed to be fragmented into 3 pieces without any additional treatment. After 2 months, the patient’s best-corrected visual acuity was 0.4 in the right eye and 1.2 in the left eye. Macular edema decreased according to optical coherence tomography. Conclusions: A case of dexamethasone intravitreal implant fragmentation during an injection procedure has not been previously reported in Korea. Although the drug fragmented, the treatment was effective without complications.

      • KCI등재

        에이엘 스캔, 자동각막굴절계, 펜타캠의 각막 굴절력 비교 분석

        박성진,임성협,이호영.Sung Jin Park. MD. Sung Hyup Lim. MD. Ho Young Lee. MD 대한안과학회 2014 대한안과학회지 Vol.55 No.7

        <b>Purpose:</b> To investigate clinical availability of AL-ScanTM (Nidek, Gamagori, Japan) by comparing corneal refractive power with AL-ScanTM, AutokeratometerTM (Topcon KR-1, Tokyo, Japan) and PentacamTM (Oculus, Wetzlar, Germany) devices. <b>Methods</b>: Seventy-one patients (142 eyes) who visited our hospital for refractive surgery were tested using AL-Scan<sup>Ⓡ, Autokeratometer and Pentacam<sup>Ⓡ and corneal refractive power was compared among devices. <b>Results:</b> When comparing measurements with AL-Scan<sup>Ⓡ, Autokeratometer and Pentacam<sup>Ⓡ, the mean corneal refractive power was 43.37 ± 1.32 D (2.4 mm zone), 43.35 ± 1.32 D (3.3 mm zone), 43.36 ± 1.35 D, and 43.35 ± 1.36 D respectively and showed no significant differences. Corneal refractive power had strongly positive linear correlation (<em>p </em>< 0.001) and Bland-Altman plots showed high degree of agreement among AL-Scan<sup>Ⓡ, Autokeratometer and Pentacam<sup>Ⓡ devices. <b>Conclusions:</b> Because measuring ocular biometry with AL-Scan<sup>Ⓡ including axial length, intraocular lens power calculation and topography simultaneously is possible, clinical use is convenient. Corneal refractive power was not different when compared with autokeratometer and Pentacam<sup>Ⓡ, thus, AL-Scan<sup>Ⓡ can be used in the clinical environment. J Korean Ophthalmol Soc 2014;55(7):984-990

      • KCI등재

        망막정맥폐쇄에서 혈압의 일중 변동 양상 분석

        박성진,문상우,임성협,윤일한,최규남,이호영,Sung Jin Park,MD,Sang Woo Moon,MD,Sung Hyup Lim,MD,Il Han Yoon,MD,Kyu Nam Choi,MD,Ho Young Lee,MD 대한안과학회 2013 대한안과학회지 Vol.54 No.9

        Purpose: The purpose of this study was to determine the diurnal blood pressure variation with retinal vein occlusion (RVO) using 24-hour ambulatory blood pressure monitoring (24-hour ABPM). Methods: The subjects in this study visited the department of ophthalmology from May 2012 to December 2012 and were diagnosed with RVO but had no history of hypertension (HTN). Non-dipper was defined as a nocturnal systolic blood pressure (SBP) decrease less than 10%. These values were used to compare the 24-hour ABPM values of the RVO and the control groups. Results: The 24-hour ABPM values, with the exception of the mean nightly SBP, were statistically different whne the RVO group was compared with the control group. The odds of an RVO patient being a non-dipper compared to dipper were 1.81 times greater than in the control. Additionally, the clinical SBP and DBP in the RVO group were not significantly different when the HTN group and the non-HTN group were compared. In contrast, the mean 24-hour SBP and the mean DBP were significantly different in regard to HTN. Conclusions: Patients with RVO have a tendency to maintain high BP throughout the day and also during the night. A patient with non-dipper status can be at risk for RVO, even if the patient does not have HTN. Therefore, 24-hour ABPM is an effective management approach for HTN in addition to strict BP control in patients with RVO.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼